Cohance Lifesciences is a global Contract Development and Manufacturing Organization (CDMO) and a leading player in the pharmaceutical industry. Formerly known as Suven Pharmaceuticals Limited, the company rebranded in May 2025 to reflect its expanded vision for collaboration and innovation. It offers comprehensive services, from custom synthesis and process R&D to the manufacturing of intermediates, Active Pharmaceutical Ingredients (APIs), and specialty chemicals for global life science and fine chemical companies.